Clinical Trials in Calgary, Alberta

Find clinical trials in Calgary, Alberta. Discover local research opportunities and treatment options in your area.

565 Active Trials Found in Calgary

Showing 565 trials on this page

Page 1 of 29

Study Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care Chemotherapy for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia

NCT ID: NCT04994717

This clinical trial is studying a new treatment approach for older adults with a type of blood cancer called Philadelphia-negative B-cell precursor acute lymphoblastic leukemia (ALL). The trial com...

Recruiting

Phase: PHASE3 Conditions: Newly Diagnosed Philadelphia (Ph)-Negative B-cell Precursor Acute Lymphoblastic Leukemia (ALL)

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

NCT ID: NCT05554393

This clinical trial, called the MyeloMATCH Treatment Trial, is studying different treatment combinations for younger patients with a type of blood cancer known as acute myeloid leukemia (AML). The ...

Recruiting

Phase: PHASE2 Conditions: Acute Myeloid Leukemia

Testing the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)

NCT ID: NCT05554406

This clinical trial, called the MyeloMATCH Treatment Trial, is investigating different treatment options for adults who have recently been diagnosed with a serious form of blood cancer called high-...

Recruiting

Phase: PHASE2 Conditions: Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm +2 more

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

NCT ID: NCT05564390

The MYELOMATCH trial is a research study designed to help people with certain types of blood cancers, specifically acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). The main goal of ...

Recruiting

Phase: PHASE2 Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndrome

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

NCT ID: NCT05675410

This clinical trial is studying whether adding two specific drugs, brentuximab vedotin and nivolumab, to the standard treatment for early-stage Hodgkin lymphoma can help patients live longer and ex...

Recruiting

Phase: PHASE3 Conditions: Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8

A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)

NCT ID: NCT05882877

This clinical trial is studying a medication called rocatinlimab to see how safe it is and how well it works for people aged 12 and older who have moderate to severe atopic dermatitis, which is a t...

Recruiting

Phase: PHASE3 Conditions: Atopic Dermatitis

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

NCT ID: NCT06172296

This clinical trial is studying a new treatment approach for children with high-risk neuroblastoma, a type of cancer that affects nerve cells. The researchers want to find out if combining a medici...

Recruiting

Phase: PHASE3 Conditions: Neuroblastoma, Ganglioneuroblastoma, Nodular

Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing Regimen, in Children From 6 Years to < 18 Years of Age With AAV.

NCT ID: NCT06321601

This clinical trial is studying a new medication called avacopan to see how well it works when used with treatments like rituximab or cyclophosphamide in children aged 6 to 17 who have a specific t...

Recruiting

Phase: PHASE3 Conditions: Vasculitis

OverTTuRe: Characteristics, Treatment Patterns and Outcomes of Patients With ATTR Amyloidosis

NCT ID: NCT06355934

The OverTTuRe clinical trial is looking at how patients with ATTR amyloidosis experience their disease before and after they are diagnosed. This study aims to gather real-world information about th...

Recruiting

Conditions: ATTR Amyloidosis

A Study Evaluating AMG 193 in Combination With Other Therapies in Participants With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous Methylthioadenosine Phosphorylase (MTAP)-Deletion (MTAPESTRY 103)

NCT ID: NCT06360354

This clinical trial is investigating a new treatment called AMG 193 for patients with advanced cancers of the gastrointestinal tract, biliary tract, or pancreas that have a specific genetic change ...

Recruiting

Phase: PHASE1 Conditions: Advanced Gastrointestinal, Biliary Tract, and Pancreatic Cancers

A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.

NCT ID: NCT06542250

This clinical trial is studying a new treatment called AZD5492, which is a special type of antibody designed to help the immune system fight certain blood cancers known as B-cell malignancies. This...

Recruiting

Phase: PHASE1 Conditions: B-cell Malignancies

LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

NCT ID: NCT06632444

The LIVERAGE™ clinical trial is studying a medication called survodutide to see if it can help adults with a liver disease known as Metabolic Dysfunction Associated Steatohepatitis (MASH) who also ...

Recruiting

Phase: PHASE3 Conditions: Liver Fibrosis, Metabolic Dysfunction Associated Steatohepatitis (MASH)

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

NCT ID: NCT06632457

The LIVERAGE™ study is researching whether a medication called survodutide can help adults with a liver disease known as non-alcoholic steatohepatitis (NASH) or metabolic-associated steatohepatitis...

Recruiting

Phase: PHASE3 Conditions: Metabolic Dysfunction Associated Steatohepatitis

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

NCT ID: NCT07100080

This clinical trial is studying a new drug called Izalontamab Brengitecan to see how well it works compared to a standard chemotherapy treatment (platinum-pemetrexed) for people with a specific typ...

Not yet recruiting

Phase: PHASE2 Conditions: Non-Small Cell Lung Cancer

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

NCT ID: NCT04752722

The LEGEND Study is a clinical trial that is investigating a new treatment called EG-70 for patients with a type of bladder cancer known as non-muscle invasive bladder cancer (NMIBC). Specifically,...

Recruiting

Phase: PHASE1 Conditions: Superficial Bladder Cancer, Non-muscle Invasive Bladder Cancer With Carcinoma in Situ

A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments

NCT ID: NCT05020236

The MagnetisMM-5 clinical trial is studying a new treatment option for people with relapsed or refractory multiple myeloma, a type of blood cancer. Researchers want to see if a medication called el...

Recruiting

Phase: PHASE3 Conditions: Multiple Myeloma

Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant

NCT ID: NCT05317416

This clinical trial is studying a new treatment called elranatamab to see if it is more effective than a standard treatment called lenalidomide for patients with newly diagnosed multiple myeloma wh...

Recruiting

Phase: PHASE3 Conditions: Multiple Myeloma

Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus

NCT ID: NCT05843643

This clinical trial is studying the safety and effectiveness of a medication called upadacitinib for adults with moderate to severe systemic lupus erythematosus (SLE), a disease that causes inflamm...

Recruiting

Phase: PHASE3 Conditions: Systemic Lupus Erythematosus

A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy

NCT ID: NCT05889182

This clinical trial is studying a medication called upadacitinib to see how effective and safe it is for treating moderate to severe hidradenitis suppurativa (HS) in adults and adolescents who have...

Recruiting

Phase: PHASE3 Conditions: Hidradenitis Suppurativa

Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)

NCT ID: NCT06057402

This clinical trial is designed for individuals with Multiple Myeloma, a type of blood cancer, who have previously participated in a related study and found benefit from a treatment called elranata...

Recruiting

Phase: PHASE4 Conditions: Multiple Myeloma